|
Dec 4
|
Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
|
|
Nov 28
|
Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
|
|
Oct 21
|
Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
|
|
Oct 19
|
Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
|
|
Oct 18
|
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
|
|
Aug 29
|
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
|